Pharmaceutical compositions and methods for treating anxiety, anxiety disorders and memory impairment using NAALADase inhibitors

Details for Australian Patent Application No. 2005237108 (hide)

Owner Guilford Pharmaceuticals Inc.

Inventors Slusher, Barbara S.

Agent Spruson & Ferguson

Pub. Number AU-A-2005237108

Parent 57851

Filing date 23 November 2005

Wipo publication date 15 December 2005

International Classifications

A61K 31/00 (2006.01)

Event Publications

8 December 2005 Complete Application Filed

15 December 2005 Application Open to Public Inspection

  Published as AU-A-2005237108

21 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005237109-A rail pad

2005237104-Device permitting a plug or a cover to lock in a detachable manner onto a frame